The new long-term results follow two-month data released at ASCO in June 2025 and are drawn from the largest prospective, randomized controlled study ever conducted among head and neck cancer ...

Tactile Systems Technology has raised its revenue guidance for FY 2018. Flexitouch is the primary growth driver for Tactile Systems technology. Line extensions are strengthening Tactile Systems ...

MINNEAPOLIS, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the ...

Leveraging over 18,000 points of feedback from patients and therapists, Tactile Medical redesigned the Flexitouch Plus garments to be easier to use, better fitting and more comfortable, all intended ...

Tactile Systems Technology’s consensus analyst price target remains steady at $16.83 per share, reflecting unchanged expectations for the company’s future valuation. This stability comes as analysts ...

Abstract Presented at ASCO 2025 Annual Meeting Features Two-Month Data from the Largest Randomized Trial Ever Conducted Among Head and Neck Cancer Survivors MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) ...

Tactile Systems Technology develops and sells medical devices for patients with lymphedema, a condition causing swelling due to lymphatic system issues, and for those needing help with airway ...

About Tactile Systems Technology Inc. Tactile Systems Technology, Inc. engages in developing and providing medical devices for the treatment of underserved chronic diseases. It provides lymphedema ...

MINNEAPOLIS, Sept. 30, 2021 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”) (Nasdaq: TCMD), a medical technology company focused on developing medical devices for the ...

MINNEAPOLIS, June 03, 2025 (GLOBE NEWSWIRE) -- Tactile Systems Technology, Inc. (“Tactile Medical”; the “Company”) (Nasdaq: TCMD), a medical technology company providing therapies for people with ...